Back the right biology

Validate targets, map disease biology, and turn multi-omics evidence into decision-ready outputs without waiting on specialist queues.

Target biology, without the wait

See how EMET supports discovery teams focused on target validation, pathway analysis, and multi-omics interpretation.

Discovery capabilities

Explore a range of sample prompts and representative outputs from EMET across the workflows below.

I'm working on MASH (metabolic dysfunction-associated steatohepatitis). Identify the top genetically supported targets from GWAS, validate causality using Mendelian Randomization, cross-reference with CRISPR essentiality and druggability, and give me a GO/NO-GO assessment for each.

gwas-associationsepigraphdb-causaldepmap-dependencyopentargets-associationspharos-targets
Target validation output showing scored targets and a go or no-go assessment.

Drug programs fail when biology is misunderstood. EMET exists to close that gap — before it closes your pipeline.

Request a Demo